MedTrace Logo

The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

NCT02612064 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 488

Last updated 2017-05-17

Study results available
· View outcomes & findings →

Summary

This single centre, dual site, comparative design study will be used to investigate the efficacy of an experimental stannous fluoride containing dentifrice in relieving dentinal hypersensitivity (DH) after short term use

Conditions

  • Dentin Sensitivity

Interventions

DEVICE

Stannous Fluoride dentifice

Experimental dentifrice containing 0.454% w/w stannous fluoride (1100ppm)

OTHER

Sodium Monofluorophosphate dentifrice

Dentifrice containing 0.76% sodium monofluorophosphate (1000ppm fluoride)

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-01
Primary Completion
2016-06-03
Completion
2016-06-03

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02612064 on ClinicalTrials.gov